Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
No Borrowings in the last few periods;
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 1,283.09% vs -24.66% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -54.52% vs -2.17% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 43.92% vs 11.64% in Mar 2024
Compare Balance Sheet Results of Astrazeneca Phar
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
5.00
45.75
-40.75
-89.07%
Share Warrants & Outstandings
Total Reserve
765.35
4,157.15
-3,391.80
-81.59%
Shareholder's Funds
770.35
4,202.90
-3,432.55
-81.67%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-41.56
-72.31
30.75
42.53%
Other Long Term Liabilities
38.45
43.40
-4.95
-11.41%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
6.32
48.10
-41.78
-86.86%
Total Non-Current Liabilities
3.21
19.19
-15.98
-83.27%
Current Liabilities
Trade Payables
456.30
215.94
240.36
111.31%
Other Current Liabilities
140.17
378.78
-238.61
-62.99%
Short Term Borrowings
0.00
2.50
-2.50
-100.00%
Short Term Provisions
106.53
30.26
76.27
252.05%
Total Current Liabilities
703.00
627.48
75.52
12.04%
Total Liabilities
1,476.56
4,849.57
-3,373.01
-69.55%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
162.41
1,417.93
-1,255.52
-88.55%
Less: Accumulated Depreciation
133.87
739.96
-606.09
-81.91%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
28.54
677.97
-649.43
-95.79%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
20.00
-20.00
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
69.97
291.22
-221.25
-75.97%
Other Non Current Assets
0.00
57.16
-57.16
-100.00%
Total Non-Current Assets
134.21
1,046.35
-912.14
-87.17%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
548.50
472.66
75.84
16.05%
Sundry Debtors
184.88
181.80
3.08
1.69%
Cash and Bank
536.70
3,110.76
-2,574.06
-82.75%
Other Current Assets
16.20
27.98
-11.78
-42.10%
Short Term Loans and Advances
56.07
12.60
43.47
345.00%
Total Current Assets
1,342.35
3,803.22
-2,460.87
-64.70%
Net Current Assets (Including Current Investments)
639.35
3,175.74
-2,536.39
-79.87%
Total Current Assets Excluding Current Investments
1,342.35
3,803.22
-2,460.87
-64.70%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
1,476.56
4,849.57
-3,373.01
-69.55%
Contingent Liabilities
98.41
223.84
-125.43
-56.04%
Total Debt
0.00
2.50
-2.50
-100.00%
Book Value per share (adjusted)
308.14
918.67
-610.53
-66.46%
Annual - Borrowings
No Borrowings in the last few periods
No Borrowings in the last few periods;
Annual - Other Long Term Liabilities
Other Long Term Liabilities 38.45 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 1,283.09% vs -24.66% in Mar 2024
Annual - Fixed Assets
Fixed Assets 28.54 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -54.52% vs -2.17% in Mar 2024
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 1,342.35 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 43.92% vs 11.64% in Mar 2024






